Low coverage of hepatitis D virus testing in individuals with hepatitis B virus and HIV, the Netherlands, 2000 to 2022. [PDF]
Boyd A +11 more
europepmc +1 more source
Reply to: Modeling challenges of hepatitis D virus kinetics during bulevirtide-based therapy. [PDF]
El Messaoudi S, Guedj J.
europepmc +1 more source
Prevalence, Risk Factors, and Clinical Profiles of Hepatitis D Virus in Nigeria: A Systematic Review, 2009-2024. [PDF]
Adepoju VA, Udah DC, Adnani QES.
europepmc +1 more source
Genetic Spatio-Temporal Analysis of Hepatitis D Virus Infection in Western Brazilian Amazon. [PDF]
Roca TP +8 more
europepmc +1 more source
Modeling challenges of hepatitis D virus kinetics during bulevirtide-based therapy. [PDF]
Mhlanga A +4 more
europepmc +1 more source
Laboratory development of an RNA quantitative RT-PCR assay reporting in international units for hepatitis D virus. [PDF]
Osiowy C, Day J, Lee ER.
europepmc +1 more source
Molecular Epidemiology, Drug-Resistant Variants, and Therapeutic Implications of Hepatitis B Virus and Hepatitis D Virus Prevalence in Nigeria: A National Study. [PDF]
Adewuyi O' +22 more
europepmc +1 more source
Hepatitis D virus infection triggers CXCL9-11 upregulation in hepatocytes and liver infiltration of CXCR3+ CD4 T cells. [PDF]
Bockmann JH +19 more
europepmc +1 more source
Advances and Challenges in Managing Hepatitis D Virus: Evolving Strategies. [PDF]
Gopalakrishna H +4 more
europepmc +1 more source

